Colowick Alan

CIK 000131616310 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001316163

Recent Transactions

40 trades

Purchase
ALUMIS INC.$ALMS
Common Stock
2025-04-02$7.49/sh+2,300→ 18,404 total
Purchase
ALUMIS INC.$ALMS
Common Stock
2025-04-01$6.97/sh+16,104→ 16,104 total
Award
Personalis, Inc.$PSNL
Stock Option (right to buy)
2023-05-17+40,000→ 40,000 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-04-01+16,456→ 16,456 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22$1.40/sh+28,571→ 28,571 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2022-06-22+10,167→ 10,167 total
Award
Personalis, Inc.$PSNL
Common Stock
2022-05-17+10,770→ 13,506 total
Award
Personalis, Inc.$PSNL
Stock Option (right to buy)
2022-05-17+15,035→ 15,035 total
Award
Personalis, Inc.$PSNL
Stock Option (right to buy)
2021-05-14+4,229→ 4,229 total
Award
Personalis, Inc.$PSNL
Common Stock
2021-05-14+2,736→ 2,736 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2021-05-04+10,167→ 10,167 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (right to buy)
2021-03-24+20,335→ 20,335 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−20,475→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−47,724→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Sale
Principia Biopharma Inc.
Common Stock
2020-07-01$60.00/sh−7,500→ 0 total
Exercise/Conversion
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-07-01−7,500→ 47,724 total
Exercise/Conversion
Principia Biopharma Inc.
Common Stock
2020-07-01$4.54/sh+7,500→ 7,500 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-06-04+10,240→ 10,240 total
Award
Personalis, Inc.$PSNL
Stock Option (right to buy)
2020-05-15+14,000→ 14,000 total
Exercise/Conversion
Principia Biopharma Inc.
Common Stock
2020-05-05$4.54/sh+6,660→ 6,660 total
Sale
Principia Biopharma Inc.
Common Stock
2020-05-05$60.00/sh−6,660→ 0 total
Exercise/Conversion
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-05-05−6,660→ 55,224 total
Exercise/Conversion
Principia Biopharma Inc.
Common Stock
2020-05-01$4.54/sh+840→ 840 total
Sale
Principia Biopharma Inc.
Common Stock
2020-05-01$60.07/sh−840→ 0 total
Exercise/Conversion
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-05-01−840→ 61,884 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2019-06-11+10,240→ 10,240 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2018-09-13+20,475→ 20,475 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−17,000→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−44,474→ 0 total
Disposition to Issuer
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-11-07−32,069→ 0 total
Award
Achaogen, Inc.
Stock Option (Right to Buy)
2017-06-14+10,000→ 10,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2017-05-25+17,000→ 17,000 total
Award
Achaogen, Inc.
Stock Option (Right to Buy)
2016-06-15+10,000→ 10,000 total
Award
Dimension Therapeutics, Inc.
Stock Option (Right to Buy)
2016-05-19+32,069→ 32,069 total
Award
Achaogen, Inc.
Stock Option (Right to Buy)
2015-03-11+20,000→ 20,000 total
Discretionary Transaction
GERON CORP$GERN
Common Stock
2008-01-02$5.73/sh+2,705→ 3,028 total
Award
Molecular Templates, Inc.
Stock Option (Right to Buy)
2006-09-27+150,000→ 150,000 total
Disposition to Issuer
Molecular Templates, Inc.
Stock Option (Right to Buy)
2006-09-26−150,000→ 0 total

Colowick Alan

Recent Transactions

Companies

Recent Filings

Address